Presented at the ASCO annual congress in Chicago in June 2019, the first results of MAPPYACTS, that we have cofunded giving 1.720.000€ thanks to the Children without Cancer races in 2017 and 2019, are promising : for 2/3 of the children whose tumor was analyzed, therapeutical targets could be identified, allowing them to benefit from targeted treatments in therapeutical trials like AcSé-ESMART.
Read the press release published in June 2019 by Gustave Roussy.
